Biocon sees FY20 as a strong year in terms of generics biz growth in US

CNBC-TV18 2019-04-26

Views 46

“Expect FY20 to be a strong year in terms of growth of our generics business in US, supported strongly with our API business” said Kiran Mazumdar Shaw, CMD, Biocon.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Sees Volume Growth Of 11-12% in FY20: Gulf Oil
play
05:33

Sees Volume Growth Of 11-12% in FY20: Gulf Oil
Confidence Petroleum's Chairman & MD Sees FY20 Revenue Growth At 45%
play
07:37

Confidence Petroleum's Chairman & MD Sees FY20 Revenue Growth At 45%
Sees FY20 Revenue Growth Between 13-15%: Bharat Electronics
play
06:21

Sees FY20 Revenue Growth Between 13-15%: Bharat Electronics
Here is what Goldman Sachs expects in terms of reform & growth in FY20
play
11:56

Here is what Goldman Sachs expects in terms of reform & growth in FY20
Implementing Generic Components Using Java 5 Generics part2
play
27:24

Implementing Generic Components Using Java 5 Generics part2
Pfizer Partners for Generics in China; Athenahealth Buys Healthcare Data Services; McDonald’s Lists Calorie Counts - Health Minute for September 18, 2012
play
01:38

Pfizer Partners for Generics in China; Athenahealth Buys Healthcare Data Services; McDonald’s Lists Calorie Counts - Health Minute for September 18, 2012
Generics in Java
play
10:47

Generics in Java
12 - Проектирование на C#. Generics. Теория
play
17:25

12 - Проектирование на C#. Generics. Теория
Bobby's World Bobby’s World S07 E005 Generics and Indians
play
19:20

Bobby's World Bobby’s World S07 E005 Generics and Indians
Why are docs raging against Aamir's generics proposal?
play
08:15

Why are docs raging against Aamir's generics proposal?
SAY NI DOK | Generics Awareness Month 2021
play
15:14

SAY NI DOK | Generics Awareness Month 2021
Arwan Pharmaceuticals: Providing Generics in Lebanon
play
01:20

Arwan Pharmaceuticals: Providing Generics in Lebanon